$VICR

VINCIARELLI PATRIZIO sold $5.4M of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $270.93 ($261.82–$277.61, $5.42M total) across 14 trades on 2026-06-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 9, 2026, 5:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 5:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The CEO/Chairman’s open-market sale totaling ~$5.42M could create short-lived negative sentiment, but the 10b5-1 plan suggests the trades were scheduled in advance.

02

Market read

A primary-source insider sale was disclosed, but the 10b5-1 framing likely limits interpretive impact.

03

What to watch

Traders may over-weight insider sales; the key is whether there are concurrent fundamental updates (earnings, guidance, contracts) not present in this text.

Relevance 5/10Novelty 8/10Timing: Filed 2026-06-09; sale executed 2026-06-08.

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s Chairman/CEO sold $5.42M of VICR shares via an open-market sale under a pre-arranged 10b5-1 plan on 2026-06-08.

Expected impact

Likely limited near-term impact; any reaction may fade unless accompanied by other fundamental/regulatory catalysts.

Evidence & confidence

The filing is a primary-source Form 4 showing a sizable sale, but it explicitly states a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity/compensation rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO; reported the sale of VICR shares.

  • Rule 10b5-1 plan

    Pre-arranged plan cited as Yes, indicating scheduled selling.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MXLHighAI 8/10

MXL vs. VICR: Which Has the Better AI Infrastructure Opportunity?

MaxLinear (MXL) and Vicor (VICR) are positioned to benefit from AI infrastructure growth. MXL reported 55% revenue growth in Q2 2026, driven by optical and electrical interconnects. Vicor focuses on power delivery for AI processors. MXL's AI products, like Keystone and Rushmore, are in high demand, with new products expected to launch in 2027 and 2028.

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: